Determinants of two-year mortality among HIV positive patients with Cryptococcal meningitis initiating standard antifungal treatment with or without adjunctive dexamethasone in Uganda.

• Main Authors: Jonathan Kitonsa (Author), Rebecca Nsubuga (Author), Yunia Mayanja (Author), Julius Kiwanuka (Author), Yofesi Nikweri (Author), Martin Onyango (Author), Zacchaeus Anywaine (Author), Abu-Baker Ggayi (Author), Freddie Mukasa Kibengo (Author), Pontiano Kaleebu (Author), Jeremy Day (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2020-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Globally, early initiation of antiretroviral therapy for HIV led to a reduction in the estimated mortality from cryptococcal meningitis (CCM) from 624,700 in 2009 to 181,100 in 2014. However, CCM remains one of the leading causes of mortality among HIV infected patients especially in sub-Saharan Afr...